Treatment with immunosuppressants does not improve kidney function, but is associated with reduced risk of vasculitis relapse in a rare…
Articles by José Lopes, PhD
Patients with ANCA-associated vasculitis (AAV) who receive Rituxan (rituximab) infusions for maintaining sustained remission fare better in the long…
A new patient-reported outcome (PRO) questionnaire for ANCA-associated vasculitis (AAV) is a reliable and feasible tool able to distinguish…
A combination treatment with Rituxan (rituximab), low-dose cyclophosphamide (Cytoxan), and tapered corticosteroids induces significant disease remission and reduces risk…
Researchers developed a new questionnaire that assesses a patient’s perspective on how anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, or AAV,…
A man who had granulomatosis with polyangiitis and small lung lesions bled in the air sacs of his lungs after…
A case report of a patient with granulomatosis with polyangiitis (GPA) along with ocular involvement suggests that Rituxan (rituximab) might…
Rituxan (rituximab) treatment is effective in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) who failed to respond to…
Rituxan (rituximab) effectively induces and maintains remission in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), a new Saudi study…
Lower levels of key immune system regulators in the kidneys of ANCA vasculitis patients may indicate more severe renal…